drugset / Trial / NCT05310292

A Glucometabolic Evaluation of Patients With Idiopathic Ketotic Hypoglycemia

NCT05310292 ↗

Non-randomizedParallel-groupOpen-labelBasic science

Summary

The project will evaluate 1) the postprandial metabolism and 2) continuous glucose levels in subjects diagnosed with Idiopathic Ketotic Hypoglycemia (IKH)) and healthy control subjects.

Timeline

Start
2022-03-21
Primary completion
2024-04-01
Completion
2025-04-01

Drugs

EvaluationDrugModalityDoseRoute
Background Acetaminophen Small molecule 1.5 g —

Indications

No indication recorded.